Mangalam Drugs and Organics share news and announcements

NSE: MANGALAMBSE: 532637Pharmaceuticals & BiotechnologySmall Cap

₹28.65₹0.92 (3.11%)BSE ₹28.00

Share price at the NSE close on 23 Oct 2026. Previous close ₹29.57.

52-week range of traded prices to 23 Oct 2026

₹22.80Low, 29 Dec 2025₹71.99High, 23 Oct 2025

Under NSE's long-term additional surveillance, stage I, on the list for 23 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.

Market cap: ₹45 Cr3,423rd largest listed
P/E: Lossover the last 12 months
P/B: 0.4
Dividend yield: Nonein the last 12 months
ROE: −30.3%
ROCE: −12.9%
Debt to equity: 1.02
Volume, NSE: 19,55176.4% delivered

Mangalam Drugs and Organics board meetings

149 filed, newest first. Page 2 of 3.

Feb 2022
- 4 Feb · Board meeting
  Board meeting held on February 04, 2022. (opens in a new tab)
Jan 2022
- 27 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2021 and other business matters (opens in a new tab)
Nov 2021
- 12 Nov · Board meeting
  Board meeting held on November 12, 2021. (opens in a new tab)
- 3 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2021 and other business matters (opens in a new tab)
Aug 2021
- 12 Aug · Board meeting
  Board meeting held on August 12, 2021. (opens in a new tab)
- 4 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters. (opens in a new tab)
Jul 2021
- 6 Jul · Board meeting
  Board meeting held on July 06, 2021. (opens in a new tab)
- 5 Jul · Board meeting
  Board meeting held on July 05, 2021. (opens in a new tab)
May 2021
- 20 May · Board meeting
  Outcome of the Board Meeting held on May 20, 2021. (opens in a new tab)
- 11 May · Board meeting
  To inter-alia consider and approve the audited financial results for the quarter / year ended March 31, 2021 and other business matters. (opens in a new tab)
Mar 2021
- 21 Mar · Board meeting
  Board meeting held on March 21, 2021 for appointment of Dr Praveen Saxena as an Additional Director (Independent Non-Executive Director) w.e.f. March 21, 2021. (opens in a new tab)
Feb 2021
- 11 Feb · Board meeting
  Board meeting held on February 11, 2021 inter alia for approval the Un-Audited Financial Results on Standalone basis for the quarter ended December 31, 2020 along with the Limited Review Report on the results pursuant to Regulation 33 of the Listing Regulations. (opens in a new tab)
- 3 Feb · Board meeting
  To consider and approve the Un-Audited Financial Results for the period ended December 31, 2020 and other Business matters. (opens in a new tab)
Nov 2020
- 12 Nov · Board meeting
  Board meeting held on November 12, 2020. (opens in a new tab)
- 4 Nov · Board meeting
  To consider and approve the un-audited financial results for the period ended September 30, 2020 and other business matters. (opens in a new tab)
Aug 2020
- 10 Aug · Board meeting
  Board meeting held on August 10, 2020. (opens in a new tab)
- 1 Aug · Board meeting
  To consider and approve the Un-Audited financial results for the period ended Jun 30, 2020 and other business matters. (opens in a new tab)
Jun 2020
- 29 Jun · Board meeting
  Board meeting held on Jun 29, 2020. (opens in a new tab)
- 21 Jun · Board meeting
  To consider and approve the financial results for the period ended March 31, 2020 and other business matters. (opens in a new tab)
Jan 2020
- 24 Jan · Board meeting
  Board meeting held on January 24, 2020 . (opens in a new tab)
- 16 Jan · Board meeting
  Pursuant to Regulation 29, 33 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, January 24, 2020 at the registered office of the Company at Mumbai, inter-alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended December 31, 2019. (opens in a new tab)
Nov 2019
- 2 Nov · Board meeting
  Board meeting held on November 02, 2019 inter-alia for approval of un-audited financial results for the quarter and half year ended September 30, 2019. (opens in a new tab)
Oct 2019
- 24 Oct · Board meeting
  To consider and approve the Un-Audited financial results for the period ended September 30, 2019 and other business items. (opens in a new tab)
Jul 2019
- 26 Jul · Board meeting
  Board meeting held on July 26, 2019. (opens in a new tab)
- 17 Jul · Board meeting
  To consider and approve the un-audited financial results for the quarter ended Jun 30, 2019. (opens in a new tab)
- 8 Jul · Board meeting
  Board meeting held on July 08, 2019. (opens in a new tab)
May 2019
- 9 May · Board meeting
  Board meeting held on May 09, 2019. (opens in a new tab)
Apr 2019
- 26 Apr · Board meeting
  To consider and approve the financial results for the period ended March 31, 2019 and other business matters (opens in a new tab)
Feb 2019
- 11 Feb · Board meeting
  Board meeting held on February 11, 2019. (opens in a new tab)
Jan 2019
- 29 Jan · Board meeting
  To consider and approve the financial results for the period ended December 31, 2018 and other business matters (opens in a new tab)
Nov 2018
- 14 Nov · Board meeting
  Board meeting held on November 14, 2018. (opens in a new tab)
- 3 Nov · Board meeting
  To consider and approve the financial results for the period ended September 30, 2018 and other business matters (opens in a new tab)
Aug 2018
- 14 Aug · Board meeting
  Board meeting held on August 14, 2018. (opens in a new tab)
- 4 Aug · Board meeting
  To consider and approve the financial results for the period ended Jun 30, 2018 (opens in a new tab)
May 2018
- 28 May · Board meeting
  Board meeting held on May 28, 2018. (opens in a new tab)
- 17 May · Board meeting
  To consider and approve the financial results for the period ended March 31, 2018 and other business matters (opens in a new tab)
Feb 2018
- 12 Feb · Board meeting
  Outcome of Board Meeting held on February 12, 2018. (opens in a new tab)
- 1 Feb · Board meeting
  Inter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter & nine months ended December 31, 2017. 2. Any other matters with the permission of the chair. (opens in a new tab)
Dec 2017
- 7 Dec · Board meeting
  Inter-alia, to consider and declare the interim dividend for the financial year 2017-18. (opens in a new tab)
Nov 2017
- 20 Nov · Board meeting
  Outcome of Board Meeting held on November 20, 2017. (opens in a new tab)
- 9 Nov · Board meeting
  Inter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter & half year ended September 30, 2017. 2. Any other matters with the permission of the chair. (opens in a new tab)
Aug 2017
- 11 Aug · Board meeting
  Outcome of Board Meeting held on August 11, 2017. (opens in a new tab)
Jul 2017
- 31 Jul · Board meeting
  11-Aug-2017 : The Company had Informed the Exchange regarding the Board Meeting Scheduled to be held on August 04, 2017 inter-alia to consider and approve the following: (1) To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter ended June 30, 2017 2. Any other matters with the permission of the chair. the company has now inform the exchange that due to unavailability of the quorum the meeting of the Board of Directors is postponed and Rescheduled August 11, 2017. (opens in a new tab)
- 27 Jul · Board meeting
  Inter-alia to consider and approve the following: (1) To approve, consider and take on record the Unaudited Financial Results along with Limited review report of the company for the quarter ended June 30, 2017 2. Any other matters with the permission of the chair. (opens in a new tab)
May 2017
- 8 May · Board meeting
  Board of Directors at their Meeting held on May 08, 2017 , inter alia transacted the following business: 1. The Board of Directors considered and took on record Audited Financial Results for the quarter and year ended March 31, 2017. 2. Other Business transacted with permission of chair. (opens in a new tab)
Apr 2017
- 28 Apr · Board meeting
  Inter-alia to consider, approve and take on record the Audited Financial Results/Statement of the company for the quarter and year ended March 31, 2017 and any other matters with the permission of the Chair. Further the Trading Window for the purpose of the said Board Meeting will remain closed from April 29, 2017 and would open 48 hours after the announcement of financial results to the public. (opens in a new tab)
Jan 2017
- 30 Jan · Board meeting
  Inter-alia to consider and approve the following:1) To approve, consider and take on record the Unaudited Financial Results of the company for the quarter and nine months ended December 31, 20162) Any other matters with the permission of the chair. (opens in a new tab)
Nov 2016
- 2 Nov · Board meeting
  Inter-alia to consider and approve the following: 1)To approve, consider and take on record the Unaudited Financial Results of the company for the quarter and half year ended 30th September, 2016 2) Any other matters with the permission of the chair. Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for all directors, officers and designated employees of the Company from November 02, 2016 and would open 48 hours after the announcement of financial results to the public. (opens in a new tab)
Jul 2016
- 23 Jul · Board meeting
  Inter-alia to consider and approve the following: 1. To approve, consider and take on record the Unaudited Financial Results of the company for the quarter ended June 30, 2016 2. Any other matters with the permission of the chair. (opens in a new tab)
Jun 2016
- 10 Jun · Board meeting
  Board of Directors at their Meeting held on June 10, 2016 has inter alia transacted the following business : Approved the allotment of balance 14,50,000 Equity Shares of Rs. 10/- each at a premium of Rs. 55/- per share pursuant to exercise of right for conversion of remaining 14,50,000 warrants into equity shares to the promoter group on preferential basis, upon the receipt of balance consideration amount on it . (opens in a new tab)

Mangalam Drugs and Organics board meetings

Feb 2022

Jan 2022

Nov 2021

Aug 2021

Jul 2021

May 2021

Mar 2021

Feb 2021

Nov 2020

Aug 2020

Jun 2020

Jan 2020

Nov 2019

Oct 2019

Jul 2019

May 2019

Apr 2019

Feb 2019

Jan 2019

Nov 2018

Aug 2018

May 2018

Feb 2018

Dec 2017

Nov 2017

Aug 2017

Jul 2017

May 2017

Apr 2017

Jan 2017

Nov 2016

Jul 2016

Jun 2016